Nanobiotix Corp

Website
245 Main St Ste 3
Cambridge, MA 02142
https://nanobiotix.com

Nanobiotix Corp is a biotechnology company based in Cambridge, MA that specializes in the development of innovative cancer therapies. They have recently achieved a significant $20 million development milestone payment for their ongoing global Phase 3 Head and Neck Cancer Study, and have also raised $55 million through a capital increase. With a strong focus on research and development, Nanobiotix is dedicated to advancing their science pipeline and collaborating with partners to bring effective treatments to patients.

Through their cutting-edge technology, Nanobiotix aims to revolutionize cancer treatment by leveraging nanomedicine to enhance the efficacy of radiation therapy. Their preliminary results from Phase 1 trials in pancreatic cancer and head and neck cancer have shown promising outcomes, further highlighting their commitment to improving patient outcomes. With a dedicated team of leaders, a scientific advisory board, and a strong presence in the media and investor community, Nanobiotix is poised to make a significant impact in the field of oncology.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Metabomed

Metabomed is a biotechnology company based in Cambridge, MA, specializing in drug discovery and development. With a focus on innovative approaches and cutting-edge technologies, Metabomed aims to address unmet medical needs and advance novel therapies for various diseases. Generated from their business information

Count Me in Inc

Count Me In Inc. is a research-focused organization based in Cambridge, MA, specializing in bioinformatics tools, resources, and databases aimed at advancing cancer informatics and transcriptomics. Their team, led by Principal Computational Scientist Brian J. Haas, PhD, is dedicated to gene discovery and genome annotation, contributing significantly to the field through numerous publications. The organization is actively involved in evaluating methods for RNA-seq fusion detection and isoform quantification, fostering collaboration in cancer research. Their work encompasses a wide range of topics, including the transcriptomic landscape of regeneration and the characterization of cancer cell lines, reflecting their commitment to understanding complex biological processes at a molecular level. Generated from the website

Epizyme

Epizyme is a global biopharmaceutical company based in Cambridge, MA, dedicated to improving patients' lives through research, innovation, and the development of transformative medicines in Oncology, Rare Disease, and Neuroscience. With a focus on areas of high unmet medical need, Epizyme is accelerating its momentum and rapidly expanding its pipeline to bring the full potential of its innovative medicines to patients. Guided by patient outcomes and supported by a culture of collaboration and excellence, Epizyme leverages its global reach and R&D firepower to partner with like-minded innovators and develop the next generation of medicines. With a strong track record in commercializing its medicines and a commitment to making a real impact for people living with high unmet medical needs, Epizyme is a leader in its field, leveraging its infrastructure, innovation, and passion to develop new therapies and valuable collaborations.Generated from the website
United States›Massachusetts›Cambridge›Nanobiotix Corp

Partial Data by Infogroup (c) 2025. All rights reserved.